Yáñez M - Search Results

1

Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease.

Yáñez M, Viña D. Yáñez M, et al. Curr Top Med Chem. 2013;13(14):1692-706. doi: 10.2174/15680266113139990120. Curr Top Med Chem. 2013. PMID: 23889051 Review.

2

Pyridazines. Part 28: 5-alkylidene-6-phenyl-3(2H)-pyridazinones, a new family of platelet aggregation inhibitors.

Sotelo E, Fraiz N, Yáñez M, Laguna R, Cano E, Brea J, Raviña E. Sotelo E, et al. Among authors: yanez m. Bioorg Med Chem Lett. 2002 Jun 17;12(12):1575-7. doi: 10.1016/s0960-894x(02)00246-9. Bioorg Med Chem Lett. 2002. PMID: 12039565

3

Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.

Yáñez M, Fraiz N, Cano E, Orallo F. Yáñez M, et al. Biochem Biophys Res Commun. 2006 Jun 2;344(2):688-95. doi: 10.1016/j.bbrc.2006.03.190. Epub 2006 Apr 17. Biochem Biophys Res Commun. 2006. PMID: 16631124

4

(-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.

Yáñez M, Fraiz N, Cano E, Orallo F. Yáñez M, et al. Eur J Pharmacol. 2006 Aug 7;542(1-3):54-60. doi: 10.1016/j.ejphar.2006.06.005. Epub 2006 Jun 10. Eur J Pharmacol. 2006. PMID: 16828740

5

Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.

Coelho A, Raviña E, Fraiz N, Yáñez M, Laguna R, Cano E, Sotelo E. Coelho A, et al. Among authors: yanez m. J Med Chem. 2007 Dec 27;50(26):6476-84. doi: 10.1021/jm061401d. Epub 2007 Nov 22. J Med Chem. 2007. PMID: 18031002

6

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F. Santana L, et al. Among authors: yanez m. J Med Chem. 2008 Nov 13;51(21):6740-51. doi: 10.1021/jm800656v. Epub 2008 Oct 4. J Med Chem. 2008. PMID: 18834112

7

Chalcones: a valid scaffold for monoamine oxidases inhibitors.

Chimenti F, Fioravanti R, Bolasco A, Chimenti P, Secci D, Rossi F, Yáñez M, Orallo F, Ortuso F, Alcaro S. Chimenti F, et al. Among authors: yanez m. J Med Chem. 2009 May 14;52(9):2818-24. doi: 10.1021/jm801590u. J Med Chem. 2009. PMID: 19378991

8

A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors.

Chimenti F, Fioravanti R, Bolasco A, Chimenti P, Secci D, Rossi F, Yáñez M, Orallo F, Ortuso F, Alcaro S, Cirilli R, Ferretti R, Sanna ML. Chimenti F, et al. Among authors: yanez m. Bioorg Med Chem. 2010 Feb;18(3):1273-9. doi: 10.1016/j.bmc.2009.12.029. Epub 2010 Jan 4. Bioorg Med Chem. 2010. PMID: 20045650

9

Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.

Alcaro S, Gaspar A, Ortuso F, Milhazes N, Orallo F, Uriarte E, Yáñez M, Borges F. Alcaro S, et al. Among authors: yanez m. Bioorg Med Chem Lett. 2010 May 1;20(9):2709-12. doi: 10.1016/j.bmcl.2010.03.081. Epub 2010 Mar 27. Bioorg Med Chem Lett. 2010. PMID: 20382016

10

Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.

Prado-Prado F, García-Mera X, Abeijón P, Alonso N, Caamaño O, Yáñez M, Gárate T, Mezo M, González-Warleta M, Muiño L, Ubeira FM, González-Díaz H. Prado-Prado F, et al. Among authors: yanez m. Eur J Med Chem. 2011 Apr;46(4):1074-94. doi: 10.1016/j.ejmech.2011.01.023. Epub 2011 Jan 21. Eur J Med Chem. 2011. PMID: 21315497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

396 results

Search Page